Singapore’s Golden Equator has punctuated a spate of fundraising activity with confirmation it will launch a $200 million mezzanine and private debt fund for growth-stage companies in Southeast Asia.
It coincides with the securing of a combined $90 million across two funds targeting publicly listed growth-stage companies from institutional and accredited investors in Singapore, Japan, and Korea. The...
India’s Innoven Capital, a joint venture between UOB and Temasek Holdings-owned Seviora Holdings, has fractionalised a USD 50m venture debt fund using blockchain and smart contracts.
OneVentures and UniQuest have led a AUD 34m (USD 23m) funding round for Vaxxas, an Australia-based biotechnology company running clinical programmes that include a needle-free COVID-19 vaccine candidate.
Temasek Holdings, A91 Partners, and Kae Capital have invested USD 135m in Indian omnichannel wellness products retailer HealthKart.